These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9365711)

  • 61. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
    DeVos JM; Gaber AO; Knight RJ; Land GA; Suki WN; Gaber LW; Patel SJ
    Kidney Int; 2012 Sep; 82(5):598-604. PubMed ID: 22622504
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".
    Donaldson P; Underhill J; Doherty D; Hayllar K; Calne R; Tan KC; O'Grady J; Wight D; Portmann B; Williams R
    Hepatology; 1993 Jun; 17(6):1008-15. PubMed ID: 8514248
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The impact of HLA-A,B match of primary renal allografts subsequent to transplant failure.
    Sanfilippo F; Goeken N; Niblack G; Scornik J; Vaughn WK
    Transplant Proc; 1987 Feb; 19(1 Pt 1):669-71. PubMed ID: 3274835
    [No Abstract]   [Full Text] [Related]  

  • 64. HLA-A incompatibility associated with enhanced long-term renal graft survival in HLA-B, DR mismatched transplants.
    Bućin D; Ekberg H; Lindholm A; Persson H; Tufveson G; Albrechtsen D
    Immunol Cell Biol; 1994 Dec; 72(6):455-60. PubMed ID: 7698817
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Revisiting HLA matching for kidney transplantation.
    Opelz G; Wujciak T; Mytilineos J; Scherer S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):173-5. PubMed ID: 8438263
    [No Abstract]   [Full Text] [Related]  

  • 66. HLA antigens in kidney allograft rejection.
    Sujirachato K; Chiewsilp P; Jirasiritham S; Mongkolsuk T; Sumethkul V
    Transplant Proc; 1996 Jun; 28(3):1272. PubMed ID: 8658656
    [No Abstract]   [Full Text] [Related]  

  • 67. Molecular matching for clinical kidney transplantation.
    Takemoto S; Terasaki PI; Maruya E; Park MS
    Transplant Proc; 1993 Feb; 25(1 Pt 1):206. PubMed ID: 7679811
    [No Abstract]   [Full Text] [Related]  

  • 68. Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28.
    Dankers MK; Roelen DL; Van Der Meer-Prins EM; De Lange P; Korfage N; Smits JM; Persijn GG; Welsh KI; Doxiadis II; Claas FH
    Transplantation; 2003 Feb; 75(3):418-20. PubMed ID: 12589169
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genomic HLA-DR compatibility in solid organ transplantation: a retrospective analysis of 1209 cases.
    Poli F; Scalamogna M; Mascaretti L; Pappalettera M; Nocco A; Crespiatico L; Cattaneo R; Lecchi L; Sirchia G
    Transplant Proc; 1995 Feb; 27(1):647-50. PubMed ID: 7879130
    [No Abstract]   [Full Text] [Related]  

  • 70. Immunogenetic factors, HCV genotypes, and HCV recurrence after liver transplantation.
    Belli LS; Zavaglia C; Alberti AB; Rondinara GF; De Carlis L; Silini E; Poli F; Scalamogna M; Tinelli C; Forti D; Ideo G
    Transplant Proc; 1999; 31(1-2):483-4. PubMed ID: 10083201
    [No Abstract]   [Full Text] [Related]  

  • 71. Impact of CREG matching on renal allograft survival in one haplotype matched transplants.
    Zafar MN; Abbas K; Muzaffer R; Hafiz S; Hussain Z; Naqvi A; Rizvi SA
    Transplant Proc; 2000 Nov; 32(7):1838. PubMed ID: 11119961
    [No Abstract]   [Full Text] [Related]  

  • 72. HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation.
    Vu LT; Baxter-Lowe LA; Garcia J; McEnhill M; Summers P; Hirose R; Lee M; Stock PG
    Arch Surg; 2011 Jul; 146(7):824-9. PubMed ID: 21768429
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Kidney transplant policy on HLA matching and waiting list.
    Adorno D; Papola F; Valeri M; Piazza A; Torlone N; Monaco PI; Provenzani L; Celeste MG; Casciani CU
    Transplant Proc; 1991 Oct; 23(5):2680. PubMed ID: 1926534
    [No Abstract]   [Full Text] [Related]  

  • 74. Modulation of the HLA-A, -B, -DR matching effect by cyclosporin therapy.
    Persijn GG; D'Amaro J; de Lange P; Schreuder GM; van Rood JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):656-8. PubMed ID: 2650212
    [No Abstract]   [Full Text] [Related]  

  • 75. HLA-A antigen incompatibility and HLA-B antigen compatibility associated with enhanced kidney allograft survival in blood-transfused patients.
    Bućin D
    Exp Clin Immunogenet; 1986; 3(3):138-44. PubMed ID: 3274633
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HLA-A, B, DR antigens and renal transplantation from cadaveric donors and living-related donors in Greek patients.
    Adam K; Polymenidis Z; Papakyriazi L; Alexopoulos E; Parapanissiou E; Antoniadis A; Papadimitriou M
    Transplant Proc; 1992 Dec; 24(6):2449-50. PubMed ID: 1465825
    [No Abstract]   [Full Text] [Related]  

  • 77. HLA compatibility and kidney grafts from unrelated live donors. Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1998 May; 30(3):704-5. PubMed ID: 9595065
    [No Abstract]   [Full Text] [Related]  

  • 78. HLA analysis of kidney transplants performed in member countries of MESOT. Middle East Society for Organ Transplantation.
    Opelz G
    Transplant Proc; 1997 Nov; 29(7):2917-9. PubMed ID: 9365613
    [No Abstract]   [Full Text] [Related]  

  • 79. Influence of HLA-DRB1* incompatibility on the occurrence of rejection episodes and graft survival in serologically HLA-DR-matched renal transplant combinations.
    Lardy NM; van der Horst AR; ten Berge IJ; Surachno S; Wilmink JM; de Waal LP
    Transplantation; 1997 Aug; 64(4):612-6. PubMed ID: 9293875
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proposal for an International Registry and Depository of Hyperacute Rejection after kidney transplantation.
    Doxiadis II; Claas FH
    Transplant Proc; 1996 Feb; 28(1):225. PubMed ID: 8644190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.